期刊语言：英语

出版地区：美国

万维提示

1、投稿方式：在线投稿。

2、期刊网址：

https://journals.lww.com/investigativeradiology/pages/default.aspx

3、投稿网址：https://www.editorialmanager.com/ir/

4、官网邮箱：IReditorialoffice@gmail.com（编辑部）

5、期刊刊期：月刊，一年出版12期。

2021年8月25日星期三

投稿须知【官网信息】

Instructions for Authors

SCOPE

Investigative Radiology publishes original, peer-reviewed reports on clinical and laboratory investigations in diagnostic imaging, the diagnostic use of radioactive isotopes, computed tomography, positron emission tomography, magnetic resonance imaging, ultrasound, digital subtraction angiography, and related modalities. Emphasis is on early and timely publication. Primarily research-oriented, the journal also includes a wide variety of features of interest to clinical radiologists.

Ethical/Legal Considerations

A submitted manuscript must be an original contribution not previously published (except as an abstract or a preliminary report), must not be under consideration for publication elsewhere, and, if accepted, must not be published elsewhere in similar form, in any language, without the consent of Wolters Kluwer. Case reports are not considered for publication by the journal.

Authorship: Submitted manuscripts may have up to seven coauthors (for a total of eight authors). All authors/coauthors must have an appropriate degree and institutional affiliation to have contributed to the manuscript. Adding coauthors in the revision stage of the peer review process will only be allowed in special instances approved specifically by the editor-in-chief, and adding authors after acceptance is not allowed. The author order cannot be changed after manuscript acceptance. Adding coauthors after manuscript acceptance is similarly not allowed. If the study is truly multi-institutional, upon request an exception may be made to allow more than 7 coauthors, with the requirement that each author individually and significantly contributed to the research and the manuscript, with this decision to be made by the editor-in-chief. Each person listed as an author is expected to have participated in the study to a significant extent.

Single first authorship is considered to be the standard of reference, and the vast majority of accepted papers fall into this category. Co-first authorship is permitted (2 first authors only), with a statement of justification required from the authors and approval by the editor-in-chief. There can only be one corresponding author, and there can be only one senior author.

Authorship credit should be based on 1) substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data; 2) drafting the article or revising it critically for important intellectual content; 3) final approval of the version to be published; 4) Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Authors should meet all four conditions.

Although the editors and reviewers make every effort to ensure the validity of published manuscripts, the final responsibility rests with the authors, not with the Journal, its editors, or the publisher.

Patient anonymity and informed consent: It is the author's responsibility to ensure that a patient's anonymity be carefully protected and to verify that any experimental investigation with human subjects reported in the manuscript was performed with informed consent and following all the guidelines for experimental investigation with human subjects required by the institution(s) with which all the authors are affiliated. Authors should mask patients' eyes and remove patients' names from figures unless they obtain written consent from the patients and submit written consent with the manuscript.

Conflicts of interest: Authors must state all possible conflicts of interest in the manuscript, including financial, consultant, institutional and other relationships that might lead to bias or a conflict of interest. If there is no conflict of interest, this should also be explicitly stated as none declared. All sources of funding should be acknowledged in the manuscript. All relevant conflicts of interest and sources of funding should be included on the title page of the manuscript with the heading “Conflicts of Interest and Source of Funding:”. For example:

Conflicts of Interest and Source of Funding: A has received honoraria from Company Z. B is currently receiving a grant (#12345) from Organization Y, and is on the speaker’s bureau for Organization X – the CME organizers for Company A. For the remaining authors none were declared.

……

更多详情：

https://edmgr.ovid.com/ir/accounts/ifauth.htm